Gillis, Steven
GlaxoSmithKline, USA,
United States
2025 Rank: 110229
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 2930 out of 166615 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 110229 | 125868 |
| Total Cites | 9597 | 10091 |
| H-index | 48 | 49 |
| Hm-index | 16 | 17 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 31 | 31 |
| Number of Single+First Authored Papers | 37 | 37 |
| Total Cites to Single+First Authored Papers | 1647 | 1685 |
| Number of Single+First+Last Authored Papers | 77 | 77 |
| Total Cites to Single+First+Last Authored Papers | 2823 | 2883 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 8403 | 8753 |
| Ratio of Total Citations to Distinct Citing Papers | 1.14 | 1.15 |
| Self-Citation Percentage |
4.90%
|
|
Gillis, Steven
Amgen Incorporated,
United States
2024 Rank: 105771
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 2867 out of 157372 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 105771 | 120829 |
| Total Cites | 9414 | 9870 |
| H-index | 48 | 49 |
| Hm-index | 16 | 17 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 27 | 27 |
| Number of Single+First Authored Papers | 34 | 34 |
| Total Cites to Single+First Authored Papers | 1607 | 1635 |
| Number of Single+First+Last Authored Papers | 74 | 74 |
| Total Cites to Single+First+Last Authored Papers | 2757 | 2807 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 8243 | 8576 |
| Ratio of Total Citations to Distinct Citing Papers | 1.14 | 1.15 |
| Self-Citation Percentage |
4.62%
|
|
Gillis, Steven
Amgen Incorporated,
United States
2023 Rank: 97917
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 2692 out of 147556 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 97917 | 112418 |
| Total Cites | 9266 | 9734 |
| H-index | 48 | 49 |
| Hm-index | 16 | 17 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 26 | 26 |
| Number of Single+First Authored Papers | 34 | 34 |
| Total Cites to Single+First Authored Papers | 1580 | 1612 |
| Number of Single+First+Last Authored Papers | 74 | 74 |
| Total Cites to Single+First+Last Authored Papers | 2709 | 2763 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 8108 | 8451 |
| Ratio of Total Citations to Distinct Citing Papers | 1.14 | 1.15 |
| Self-Citation Percentage |
4.81%
|
|
Gillis, Steven
Amgen Incorporated,
United States
2022 Rank: 88837
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 2517 out of 138599 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 88837 | 101871 |
| Total Cites | 9084 | 9546 |
| H-index | 47 | 49 |
| Hm-index | 16 | 17 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 26 | 26 |
| Number of Single+First Authored Papers | 33 | 33 |
| Total Cites to Single+First Authored Papers | 1559 | 1590 |
| Number of Single+First+Last Authored Papers | 73 | 73 |
| Total Cites to Single+First+Last Authored Papers | 2666 | 2717 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 7939 | 8280 |
| Ratio of Total Citations to Distinct Citing Papers | 1.14 | 1.15 |
| Self-Citation Percentage |
4.84%
|
|
Gillis, Steven
Tufts Medical Center,
United States
2021 Rank: 85784
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 2474 out of 127911 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 85784 | 98384 |
| Total Cites | 8880 | 9327 |
| H-index | 46 | 48 |
| Hm-index | 16 | 17 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 25 | 25 |
| Number of Single+First Authored Papers | 35 | 35 |
| Total Cites to Single+First Authored Papers | 1532 | 1563 |
| Number of Single+First+Last Authored Papers | 75 | 75 |
| Total Cites to Single+First+Last Authored Papers | 2615 | 2668 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 7761 | 8089 |
| Ratio of Total Citations to Distinct Citing Papers | 1.14 | 1.15 |
| Self-Citation Percentage |
4.79%
|
|
Gillis, Steven
Amgen Incorporated,
United States
2020 Rank: 77542
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
None
Rank in SubField 1: 2212 out of 108509 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 77542 | 89172 |
| Total Cites | 8689 | 9144 |
| H-index | 46 | 47 |
| Hm-index | 16 | 17 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 24 | 24 |
| Number of Single+First Authored Papers | 34 | 34 |
| Total Cites to Single+First Authored Papers | 1494 | 1531 |
| Number of Single+First+Last Authored Papers | 74 | 74 |
| Total Cites to Single+First+Last Authored Papers | 2549 | 2608 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 7602 | 7930 |
| Ratio of Total Citations to Distinct Citing Papers | 1.14 | 1.15 |
| Self-Citation Percentage |
4.98%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.